BioSpace News Archive

Relay Medical recently announced the closing of a private placement offering of over $8.5M to fund and accelerate the Company’ continued development and evolving/expanding commercial operations.

Interim Data Showed GT005 Was Well Tolerated in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) Majority of Patients Treated with GT005 Had Increases in Complement Factor I (CFI) Levels, with an Average Increase of 146% Compared to Baseline Interim Data Demonstrated Potential for Single Administration of GT005 to Down-Regulate Overactive Complement System, a Key Driver of AMD

Physicians Endoscopy and Ambulatory Center for Endoscopy, LLC (ACE), in partnership with Holy Name Medical Center, are pleased to announce the acquisition of Hudson Bergen Endo Surgical Center (formerly Hudson Bergen Medical Center). Hudson Bergen Endo Surgical Center will formally become a second location for the existing Ambulatory Center for Endoscopy, LLC

Protein Metrics Inc., a leading provider of biopharmaceutical and proteomics analysis software, announced today the addition Kevin Cronin, Vice President of Corporate Development, to their leadership team.

AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States, announced today that it will release its financial results for the fourth quarter and full year ended December 31, 2020 before the opening of the financial markets on Thursday, March 4, 2021

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Seagen Inc. (Nasdaq: SGEN) today announced results from the second cohort (cohort 2) of patients in the pivotal phase 2 single-arm EV-201 trial. In the trial, 52 percent of patients who received PADCEV®

Integrated BioPharma, Inc. reports its financial results for the quarter ended December 31, 2020.

Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced the closing of its previously announced underwritten public offering in the United States of 16,428,572 American Depositary Shares (“ADSs”) representing 16,428,572 ordinary shares,

Surgalign Holdings, Inc., a global surgical implant company, announced that its 2021 Annual Meeting of Stockholders will be held virtually on May 4, 2021 at 9:00 A.M. Central Time.

Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that management will present at the Winter Wonderland – Best Ideas from the Buy-side Conference. The conference is being held virtually on February 16 th through February 19 th .